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NMR IN BIOMEDICINE 1
Structural and resting-state MRI detects regional
brain differences in young and mid-age healthy
APOE-e4 carriers compared to non-APOE-e4
carriers
Nicholas G Dowell1,Simon L Evans2, Paul S Tofts1, Sarah L King2, Naji Tabet1 and Jennifer M Rusted2
Abstract—The presence of the e4 allele of apolipoprotein E
(APOE) gene is the best known genetic risk factor for Alzheimer’s
disease. In this study we investigated the link between functional
and behavioural differences and regional brain volume and
cortical thickness differences between those that carry the e4
allele (e4+) and those that only carry the e3 allele (e3/e3). We
studied these genotype populations in two age groups: a young
group (average age 21 years); and a mid-age group (average age
50 years). High-resolution T1-weighted MRI scans were analyzed
with Freesurfer to measure regional white matter brain volume
and cortical thickness differences between genotype groups at
each age. This data was correlated against behavioural findings
on the same cohort. Resting-state MRI was also conducted to
identify differences in underlying brain functional connectivity.
We found that there is a positive correlation between the thickness
of the parahippocampal cortex in young e4+ and performance
on an episodic memory task. Young e4+ also showed a positive
correlation between white matter volume in the left anterior
cingulate and performance on a covert attention task. At mid
age, e4+ had structural differences compared to e3/e3 in these
areas: the parahippocampal cortex was thicker and white matter
volume in the left anterior cingulate was greater than e3/e3. We
discuss the possibility that an over-engagement with these regions
by e4+ in youth may have a neurogenic effect that is observable
later in life. The cuneus appears to be an important region for
APOE-driven differences in the brain, with greater functional
connectivity among young e3/e3 and greater white matter volume
in the young e4+.
Index Terms—apolipoprotein E e4; cortical thickness; white




ERHAPS the greatest challenge facing health services
around the world is the rise in age-related memory loss
and dementia. The global societal costs of dementia were
estimated to be 818 billion USD in 2015 (1), and this is
expected to rise to over 1 trillion USD by 2030. Given the
enormity of this public health challenge, there is particular
interest in understanding factors that influence Azlheimer’s
disease (AD) risk and identifying early markers in the genesis
of dementias. The best established genetic risk factor for AD
is associated with the apolipoprotein E (APOE) gene (2-4),
which codes for a protein that is responsible for lipid and
cholesterol transport to cell membranes throughout the body.
1Brighton and Sussex Medical School, Brighton, UK. .
2School of Psychology, University of Sussex, Brighton, UK..
The APOE gene exists in three different isoforms (alleles),
labelled epsilon 2, epsilon 3 and epsilon 4 (henceforth e2,
e3 and e4 respectively). Each person carries two alleles, the
most prevalent is the e3 form and is present in 77% of the
population, 25% carry the e4 variant, while 15% carry the
e2 form (5). Carriers of a single e4 allele face a 2-3 fold
increase in the risk of developing AD compared to those with
a double-e3 configuration, while those with two e4 alleles
have a dramatically increased risk of up to 15 times (6). In
contrast, those carrying at least one e2 allele could see their
risk of AD reduced by half (7). In this paper, those who carry
at least one e4 allele are termed e4+, those who do not are
e4-, while homozygous e3 carriers are termed e3/e3. The e4
allele has also been shown to affect cognitive performance
in healthy ageing: e4+ show poorer performance on tests of
memory function relative to e4- in later life (8,9). Longitudinal
studies have shown that e4+ experience greater cognitive
decline across the lifespan (10,11). The e4 allele has clear
negative consequences in later life but, paradoxically, there
is evidence that it might confer some cognitive advantages
in young adulthood (12-14). This has led to the suggestion
that the e4 allele might represent an example of antagonistic
pleiotropy (15,16), where a gene impacts fitness differently
across the lifespan. Under this hypothesis, mid adulthood
would represent a transition point for e4+ as cognitive ad-
vantages give way to disadvantages. Although mid age likely
represents the best time point to deliver intervention strategies
to protect e4+ against imminent cognitive decline (17), most
of the work exploring APOE effects on neural structure and
function has focused on later life. In this work, we set out
to explore APOE effects on brain structure in both young
adulthood and mid-age. We also explored whether structural
indices could be linked to cognitive performance, and analyzed
APOE effects on measures of resting state functional brain
activation.
As well as a focus on later life cognition, many neuroimag-
ing studies of APOE effects have also paid particular attention
to hippocampal structure and function, since AD pathology
first becomes apparent in the hippocampal formation (18). In
healthy older adults, some studies have shown e4+ to have
smaller hippocampal volumes (19,20) although subsequent
work found the effect to only be present longitudinally (20),
restricted to homozygous e4+ (21), or not present at all
(22,23). A small number of studies have examined similar
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effects in healthy young adults: one study has reported reduced
hippocampal volume in e4+ aged 20-38 (24), another reported
reduced entorhinal cortical thickness in adolescents (25), yet
another study in adolescents found no effects (26). Thus, the
link between APOE status and hippocampal volume in healthy
ageing is by no means clear. Measures of cortical thickness in
the hippocampal subregions have shown that e4+ aged 45-55
years suffer a thinning of the entorhinal cortex and subiculum:
overall volume only differed at the trend level, suggesting
that APOE effects could be more localised, which could help
explain inconsistencies in findings (27).
Although there are many imaging studies that have inves-
tigated the structural links between grey matter and APOE
status, there are comparatively few that have studied the white
matter. However, in the last few years there has been rapidly-
growing interest in this area and genotype-dependent white
matter differences have been found that accompany grey mat-
ter. Recent studies (28-30) have shown that there is detectable
white matter disruption in these areas in individuals in the
prodromal stages of AD as well as neuronal degeneration and
volume loss (31).
The parahippocampus is adjacent to the hippocampus and
comprises the entorhinal and perirhinal cortices and, coupled
with the posterior cingulate, plays an important role in memory
processing and storage. Cortical thinning has been identified
in the parahippocampal gyrus in AD (32) and in carriers of
an APOE promoter gene a recent study suggests that this
region is affected by genotype polymorphism (33). In addition,
a recent resting-state study has suggested that the parahip-
pocampal gyrus may exhibit deviant functional connectivity
in cognitively normal elderly e4+ individuals (34).Studies
exploring functional activation levels in the resting state have
implicated the hippocampus as a locus for APOE effects (35-
37); other studies have shown aberrant hippocampal activity
in e4+ during memory tasks (35,38), and also during tasks
that do not typically engage the hippocampus (14,39). Some
authors have suggested that these effects relate to future AD
risk, possibly reflecting early functional compensation. Resting
state MRI studies have also pointed to differences in default
mode network (DMN) activity. Altered coactivity within the
DMN has been reported in both young adult (35) and healthy
older e4+ (40), and is of significance because AD pathology
seems to favour regions employed by the DMN (41), with
AD patients showing disrupted DMN coactivity (42). Activity
within the anterior cingulate cortex (ACC), a core node within
the DMN, has been shown to be affected by APOE status.
Using arterial spin labelling, it has been shown that cerebral
blood flow (CBF) in the ACC is reduced in older e4+ but
increased in young adult e4+. Furthermore, increased CBF
in the left ACC was positively correlated with executive
functioning in young adult e4+ only (43). Functional imaging
studies have also pointed to the ACC as a potential locus
for APOE related differences, perhaps driven by alterations
in CBF. In individuals aged 49-75, it has been shown that
e4+ under-recruit their ACC during a semantic categorisation
task; abnormal responses in right hippocampus were also
observed (44). In young to middle-aged adult e4+, reduced
grey matter volume has been reported in ACC (45). The
posterior cingulate cortex also forms a core DMN node, and
APOE effects have been reported in this region also, with
e4+ (aged 49-67) showing reduced glucose metabolism (46).
Enhanced connectivity between hippocampal and posterior
cingulate regions has been reported in young adult e4+ (47).
Our recent work has suggested that another region, the
cuneus, might also be a site whose activity might differentiate
e4+ from e4- (48). Using functional MRI, we explored activa-
tion patterns during tasks of prospective memory and covert
attention, in two age groups of healthy individuals. We tested
e4+ and e3/e3 in young adulthood (aged 18-28) and mid age
(aged 45-55). Results suggested a pattern of decreased activity
in the cuneus in mid-age e4+ only, which we interpreted as
reflecting accelerated neural ageing in e4+. Healthy elderly
individuals show decreased activity in the cuneus (reliably
demonstrated across a range of cognitive paradigms), thought
to reflect impoverished processing of visual sensory input
(49,50). Thus mid-age e4+ seem to show a pattern of neural
recruitment normally seen in older adults, suggesting accel-
erated ageing. Interestingly, the cuneus seems to be one of
the first sites where amyloid is deposited (51,52). PET studies
have also shown that AD causes a shift in glucose metabolism
in the brain, away from the cuneus to more frontal regions
(53), again suggesting that the cuneus is affected early in AD
disease progression. In the neighbouring precuneus, we found
that healthy young adult e4+ showed a a failure to deactivate
during functional imaging of the covert attention task (14).
The precuneus is also a key region in the DMN, and resting
state studies have found disrupted precuneus connectivity in
healthy older e4+ (54).
In spite of these differences between e4+ and e4-, there
been relatively few human studies that have correlated the
behavioural and structural findings (55,56). A general link
between brain anatomy and function might be expected since
the efficiency of neural processing depends on the number, size
and configuration of neurons, together with the number and
type of synaptic connections they make (57). A recent study
has uncovered the intriguing possibility that neuronal activity
is a key factor in driving the growth of new neurons, and this
effect has been identified in the hippocampal dentate gyrus and
subventricular zone (58). This implies that differences in brain
activation levels, such as those observed between e4+ and e4-,
could stimulate changes in brain volume and structure.
In this work, we investigate whether structural MR imag-
ing data can detect subtle regional brain volume or cortical
thickness differences between e4+ and e3/e3, at two narrowly
defined age ranges reflecting young adulthood and mid-age.
Based on the findings outlined above, our a priori regions of
interest were the key brain areas of parahippocampus, anterior
cingulate, posterior cingulate, cuneus and precuneus. This
study is not limited to grey matter regions only; in addition
to measuring cortical thickness we also calculate white matter
volume ratios in these areas, since there is a growing body of
research that has identified subtle changes to the connecting
white matter regions (29,30,59). Furthermore, a study of
white matter has additional importance when considering the
potential link between neurogenic processes and genetics-
driven brain function. Given the important strong association
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of hippocampal changes with aging and dementia, we study
this brain area by additionally measuring the hippocampal
grey matter volume ratio. We use behavioural data collected
from the same individuals to investigate links between brain
structure and behavioural performance, and assess the possi-
ble influence of APOE status. These behavioural data have
been published elsewhere (14,48). We evaluated correlations
between parahippocampal cortical thickness and performance
on a 20-item word recall task. For the cuneus, precuneus and
anterior cingulate, we used a measure of attentional switching
performance derived from a covert attention task to investigate
links between brain volume and behaviour in these regions.
These measures were selected as being most appropriate
given the putative functions of the regions under study. No
correlations were assessed for the posterior cingulate, since
there is insufficient evidence to link it to either task. Finally,
we report data from resting-state MRI analyses in the same
individuals. We hypothesized that the resting state analyses
would show disrupted DMN coactivation as suggested by
previous studies (60). We also hypothesized that resting state
differences would co-localise with structural effects, which,
alongside behavioural correlates, could point to the functional
significance of any structural differences.
II. METHODS
A. Participants and genotyping
Ninety-eight healthy young participants were recruited (age
20 ± 2 years (mean ± SD), range 18 – 30 years, 64 females,
34 males), and 78 healthy mid-age participants were recruited
(age 51 ± 3 years, range 43 – 58, 44 females, 34 males); all
participants were right-handed. Volunteers were excluded from
the study for untreated high blood pressure, cardiac pathology,
a history of psychiatric or neurological illness, current use of
psychoactive medication, and presence of metallic implants
including bridges and braces, or tattoos above the shoulder.
All participants were non-smokers (and had been for at least
5 years), had a body mass index within the normal range
and had English as their first language. Initial screening
involved signing of written informed consent (following pro-
cedures approved by the University of Sussex Schools of
Psychology and Life Sciences Research Ethics Committee),
and cheek swab samples were collected for DNA analysis
from each participant. APOE genotypes were determined by
KBiosciences (Hoddesdon, UK; www.kbioscience.co.uk), us-
ing their own system of fluorescence-based competitive allele-
specific polymerase chain reaction (KASPar). Two APOE
single-nucleotide polymorphisms (SNPs) rs429358 and rs7412
allowed identification of the three major APOE alleles (e2, e3
and e4).
1) Young group: From the samples, 9 participants were
heterozygous e2 and excluded from the study. 50 were e3/e3,
of which 20 were willing and eligible to participate; providing
a control group representing the genotype most frequent in the
general population (61). From the remaining 34 volunteers
who were e4+, we were able to recruit 21 of the group to
be participants to enter our experimental group. This group
included two participants that were homozygous e4 carriers.
2) Mid-age group: From the anonymized samples, 9 partic-
ipants were found to be heterozygous e2 and excluded from the
study. Forty-seven were e3/e3, and the remaining 22 volunteers
were e4+. All participants who coded as e4+ were invited to
take part in the study as the experimental group. The same
number of participants who coded for e3/e3 were recruited as
the control group. Twenty individuals from the e3/e3 group,
and 17 individuals from the e4+ group returned; this group
included three homozygous e4 carriers.
Volunteers signed written informed consent, following
procedures approved by the relevant Ethics Committees.
The genotype results, imaging and behavioural data were
anonymized and compiled by a third party so that neither
volunteers nor the researchers were aware of the genotype
results.
Demographics are shown in Table 1. Independent two-tailed
t-tests demonstrated that there were no significant (p > 0.05)
differences in age, IQ or years in education between our
genotype groups at young age (Table 1a) or at mid age (Table
1b).
Table I
VOLUNTEER CHARACTERISTICS AND MEASURES OF BASELINE COGNITIVE
PERFORMANCE FOR THE YOUNG AND MID-AGE GROUPS. STANDARD
DEVIATIONS IN PARENTHESES.
Genotype Group Age (years) Gender IQ Years in education
Young group
e4+ (n=21) 21.4 (2.2) 13F 113 (4) 15.1 (0.2)
e3/e3 (n=20) 20.9 (1.4) 14F 115 (3) 15.1 (0.3)
t statistic t = 0.82 t= 0.02 t = 0.18
p value p = 0.42 p = 0.23 p = 0.56
Mid-age group
e4+ (n=17) 49.4 (3.9) 12F 119 (5) 15.0 (1.55)
e3/e3 (n=20) 50.5 (4.5) 11F 121 (4) 14.6 (1.57)
t statistic t = 0.85 t= -1.97 t= 0.75
p value p = 0.39 p = 0.10 p = 0.51
B. Magnetic resonance imaging protocol
All images were acquired on a Siemens 1.5 T Avanto
MRI scanner (Siemens, Erlangen, Germany). High-resolution
anatomical images were acquired using a 3D T1-weighted
MPRAGE sequence, using TR = 1160 ms, TE = 4.44 ms, TI
= 600 ms with a FOV = 230 x 230 mm2. The acquisition
matrix was 256 x 256, the flip angle = 15°, resulting in
voxel dimension of 0.9 x 0.9 x 0.9 mm3. Acquisition time
was 5 min. B0 gradient echo fieldmaps were acquired with
TR = 513 ms, TE = 5.78 mm, FOV = 192 mm, acquisition
matrix = 64 x 64 and a flip angle of 60°. The resulting voxel
dimensions were 3 x 3 x 3 mm3. Acquisition time was 1
min. Resting state fMRI was acquired over a 7 minute period;
participants were instructed to keep their eyes open and not
fall asleep: no further instructions were given. There was no
visual stimulation apart from the dim lighting in the scanner
room. Thirty-six 3 mm slices (0.75 mm interslice gap) were
acquired with an in-plane resolution of 3 mm × 3 mm (TR =
3300 ms per volume, TE = 50 ms).
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C. Resting state fMRI analysis
Image pre-processing and analysis was conducted using
FSL MELODIC and the FSL pre-processing tools. Pre-
processing consisted of motion correction, brain extraction,
spatial smoothing using a Gaussian kernel of full-width at
half maximum (FWHM) of 5 mm, and a high-pass temporal
filter was set to 150 s (0.007 Hz). Each participant’s dataset
of 130 volumes was then registered to their structural scan.
Independent Component Analysis (ICA) as implemented in
MELODIC was then used to decompose the temporally con-
catenated datasets into 20 independent components. The set
of spatial maps from the group-average analysis was used
to generate subject-specific versions of the spatial maps, and
associated time series, using dual regression (35). First, for
each subject, the group-average set of spatial maps is regressed
(as spatial regressors in a multiple regression) into the subject’s
4D space-time dataset. This results in a set of subject-specific
time series, one per group-level spatial map. Next, those time
series are regressed (as temporal regressors, again in a multiple
regression) into the same 4D dataset, resulting in a set of
subject-specific spatial maps, one per group-level spatial map.
We then tested for main effects of genotype using FSL’s
randomise permutation-testing tool. Classification of resting
state networks was performed by two independent raters.
Results are presented at a significance threshold of p<0.05
FDR-corrected.
D. Structural MRI analysis
In this study, we report measures of cortical thickness
and white matter volume in the important brain regions of
the cuneus (left+right hemisphere), anterior cingulate, and
the parahippocampus (left+right hemisphere) shown in Fig-
ure 1. These metrics were obtained following cortical re-
construction and volumetric segmentation of subjects’ T1-
weighted MPRAGE images using the Freesurfer image anal-
ysis suite (http://surfer.nmr.mgh.harvard.edu). The reconstruc-
tion pipeline employed by Freesurfer includes motion correc-
tion (62) and the exclusion of non-brain tissue was performed
using a hybrid watershed/surface deformation procedure (63).
Images are transformed to Talairach space and the subcor-
tical white matter and deep grey matter structures are seg-
mented (64,65). Tessellation and surface deformation of the
white/grey and grey/CSF border is employed to improve the
reliability of the segmentation (66) and images are registered
to a spherical atlas that matches individual cortical folding
patterns to cortical geometry across subjects. This allows
the extraction of cortical thickness (defined as the distance
between grey/white matter boundary and the grey matter/CSF
boundary) (66). To account for the differences in head size,
we normalized the volume of segmented regions by dividing
by the estimated total intercranial volume to give a volume
ratio. Cortical thickness measures are not normalized since
thickness measures do not scale linearly with head size. In
only 4 subjects, minor manual edits were required to improve
the accuracy of the pial and white matter surfaces in the
temporal lobes as estimated by Freesurfer. Cortical thickness
and white matter volumes for 6 regions (parahippocampus,
cuneus and left and right anterior cingulate, precuneus and
posterior cingulate) were compared statistically using a two-
tailed t-test (equal variances assumed) in SPSS version 22. An
adjusted (Bonferroni-corrected) significance level of p=0.008
was used for each region. Age and gender were included as
covariates of no interest in the statistical analysis to account
for any gender by genotype interactions. However, such effects
are mainly observed in older individuals (60+ years) (17) and
we did not anticipate any effects on either of our cohorts.
E. Correlation with behavioural measures
Localized volume and thickness changes in the cuneus,
precuneus, parahippocampus, and anterior cingulate were cor-
related with behavioural indices that are known to recruit these
specific brain areas. The posterior cingulate is not strongly
associated with either the memory or covert attention tasks
performed in this study, and was not included in this analysis.
The behavioural data used for the correlations are summarized
in Table 2. This data has been published elsewhere (14,48)
together with a detailed statistical analysis and discussion
of the genotype- and age-dependent differences that were
observed. In summary, a main effect for age was identified
in the covert attention task (p=0.001) together with a main
effect of genotype in the mid-age group (p=0.039) with e4+
showing better task performance.
Given the well-established role of the hippocampus in
supporting memory, we correlated episodic memory perfor-
mance and parahippocampal thickness. Episodic memory was
measured using immediate free recall of a supraspan unrelated
word list. Participants are presented with 20 unrelated words
on-screen at a rate of one word every two seconds; after all 20
words have been presented they are prompted for immediate
written recall.
The cuneus and anterior cingulate has been shown to be
recruited during a covert attention (CA) task (67). Thus, we
correlated attentional switching and anterior cingulate and
cuneus volume. The CA task (based on (67)) is a computer-
based task which involves target detection following a cue. In
each trial, participants fixate a small diamond in the centre
of the screen; after a 3000ms delay one side of the diamond
changes colour briefly, cueing either left or right. The target
is then displayed to either the left or right of the diamond.
The cue is predictive in 70% of trials (cue congruent), and
incorrect for the remaining 30% of trials (cue incongruent).
Participants indicate with a left or right button response which
side of the screen the target appears. The validity effect (the
outcome measure) is calculated by subtracting the reaction
times to congruent from incongruent trials; a smaller validity
effect indicates faster attentional switching on invalidly-cued
trials and better task performance.
To assess correlations, Pearson’s product-moment correla-
tion coefficients were calculated (r and p values are reported
in Tables 4 and 5). The data met all assumptions for the use of
this test. Further details of the behavioural data are described
elsewhere (14).
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Figure 1. Representative volume masks for the regions that show significant genotype differences: (a) anterior cingulate, (b) cuneus, (c) parahippocampus.
The white matter regions are coloured red and the grey matter regions are yellow. The slice positions for the sections are given in the figure.
III. RESULTS
A. Cuneus
White matter volume: Normalized white matter volume
ratios in the cuneus were significantly greater in young adult
e4+ (T=4.2, p<0.001), but there was no difference between
genotype groups at mid age (Table 3). Cortical thickness: No
significant genotype differences were observed in either age
group. Correlations with performance on covert attention task:
In young adults, there was a significant positive correlation
between cuneus white matter volume and task performance in
e4+, but not in e3/e3. At mid age, there was a trend to positive
correlation in e3/e3 but not in e4+ (Table 4, Figure 2).
B. Anterior cingulate white matter
White matter volume: In the young adult group, white
matter volume in the anterior cingulate was not significantly
different between e4+ and e3/e3 for either age group. This
is surprising given that previous findings have revealed the
anterior cingulate is affected by APOE status. In light of this,
and a recent perfusion study (43) that showed genotype-driven
differences were lateralized to the left anterior cingulate, we
decided to extend our study to the left and right anterior cin-
gulate separately. This revealed that the white matter volume
of the left anterior cingulate among the mid-age cohort was
greater in e4+ (Table 3), and trending towards significance
(T=2.6, p=0.014). Cortical thickness: No significant genotype
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Table II
PERFORMANCE ON COVERT ATTENTION TASK AND EPISODIC MEMORY TASK BY GENOTYPE. STANDARD DEVIATIONS ARE GIVEN IN PARENTHESES.
Age Genotype Covert Attention Task Episodic Memory
RT (ms) to validly cued trials RT (ms) to invalidly cued trials Validity effect (ms) (recalled words, max 20)
Young
e4+ 358(50) 387(58) 26(5.5) 9.0 (2.7)
e3/e3 329(72) 371(67) 42 (5.4) 9.7 (2.9)
Mid
e4+ 422(84) 476(108) 54(44) 6.9 (2.3)
e3/e3 393(90) 457(78) 64 (25) 7.9 (2.1)
Table III
TABLE 3. MEAN CORTICAL THICKNESS AND WHITE MATTER VOLUME RATIOS FOR THE PARAHIPPOCAMPUS (LEFT+RIGHT HEMISPHERE), CUNEUS
(LEFT+RIGHT HEMISPHERE), POSTERIOR CINGULATE (LEFT+RIGHT HEMISPHERE) AND ANTERIOR CINGULATE (LEFT AND RIGHT HEMISPHERE).
STANDARD DEVIATIONS ARE GIVEN IN PARENTHESES. THE P-VALUES SHOWN IN BOLD ARE BELOW THE BONFERRONI SIGNIFICANCE THRESHOLD,
THOSE IN BOLD-ITALICS INDICATE TRENDS ONLY.
Brain region Young Mid
e4+ e3/e3 p value e4+ e3/e3 p value
WM volume ratio (x10−3)
Parahippocampus 2.2 (0.3) 2.1 (0.3) 0.396 2.2 (1.5) 2.3 (0.2) 0.389
Cuneus 3.3 (0.3) 2.9 (0.4) <0.001 3.2 (0.4) 3.4 (0.4) 0.205
Precuneus 12.6 (1.4) 12.1 (1.7) 0.31 12.9 (1.7) 12.6 (1.5) 0.588
Left anterior cingulate 1.8 (0.3) 1.8 (0.3) 0.668 1.9 (0.2) 1.8 (0.1) 0.014
Right anterior cingulate 2.0 (0.2) 1.9 (0.2) 0.85 2.1 (0.3) 2.0 (0.3) 0.611
Posterior Cingulate 5.4 (0.4) 5.4 (0.5) 0.508 5.6 (0.5) 5.6 (0.3) 0.937
Cortical Thickness (mm)
Parahippocampus 3.1 (0.2) 3.1 (0.3) 0.698 3.0 (0.1) 2.8 (0.2) 0.006
Cuneus 1.9 (0.1) 1.8 (0.1) 0.454 1.8 (0.1) 1.8 (0.1) 0.358
Precuneus 2.6 (0.2) 2.5 (0.1) 0.177 2.4 (0.1) 2.4 (0.1) 0.659
Left Anterior Cingulate 2.7 (0.2) 2.7 (0.2) 0.938 2.5 (0.1) 2.6 (0.1) 0.244
Right Anterior Cingulate 2.7 (0.2) 2.7 (0.2) 0.719 2.5 (0.2) 2.5 (0.1) 0.215
Posterior Cingulate 2.8 (0.2) 2.9 (0.2) 0.522 2.6 (0.1) 2.7(0.1) 0.473
Hippocampus* 5.6 (0.3) 5.6 (0.6) 0.634 5.6 (0.5) 5.7 (0.4) 0.309
* hippocampus grey matter volume ratio (x10−3).
Table IV
CORRELATIONS BETWEEN TASK PERFORMANCE AND WHITE MATTER VOLUME MEASURES. THE P-VALUES SHOWN IN BOLD ARE BELOW THE
BONFERRONI-CORRECTED SIGNIFICANCE THRESHOLD.
Age Genotype Cuneus volume and validity effect Left anterior cingulate volume and validity effect Parahippocampal volume and episodic memory
Young e4+ r = -0.63, p = 0.005 r =-0.595, p = 0.009 r = -0.286, p = 0.236
e3/e3 r = -0.165, p = 0.501 r = 0.167, p = 0.494 r = -0.220, p = 0.380
Mid e4+ r = 0.220, p = 0.395 r = -0.466, p = 0.059 r = 0.126, p = 0.631
e3/e3 r= -0.545, p = 0.029 r= -0.115, p = 0.671 r= -0.02, p = 0.939
Table V
CORRELATIONS BETWEEN TASK PERFORMANCE AND CORTICAL THICKNESS MEASURES. THE P-VALUES SHOWN IN BOLD ARE BELOW THE
BONFERRONI-CORRECTED SIGNIFICANCE THRESHOLD.
Age Genotype Cuneus thickness and validity effect Left anterior cingulate thickness and validity effect Parahippocampal thickness and episodic memor
Young e4+ r = -0.047, p = 0.852 r =-0.099, p = 0.697 r = 0.590, p = 0.008
e3/e3 r = -0.218, p = 0.370 r = -0.542, p = 0.017 r = 0.048, p = 0.846
Mid e4+ r = 0.388, p = 0.124 r = -0.134, p = 0.608 r = 0.307, p = 0.231
e3/e3 r= 0.154, p = 0.568 r= -0.109, p = 0.687 r= 0.044, p = 0.861
differences were observed in either age group. Correlations
with performance on covert attention task: There was a sig-
nificant positive correlation between task performance and
normalized left anterior cingulate white matter volume in
young adult e4+ only (Table 4, Figure 2).
C. Parahippocampus
White matter volume: No significant genotype differences
in white matter volume were detected at either age group.
Cortical thickness: In the young adult group, there were no
significant genotype-dependent differences in parahippocam-
pal thickness. At mid age, parahippocampal thickness was
significantly greater in e4+ (T=2.9, p=0.006; Table 3). Corre-
lations with performance on episodic memory task: Number of
words recalled was positively correlated with parahippocampal
thickness in young adult e4+ only (Table 5, Figure 2).
D. Posterior cingulate and precuneus
White matter volume: No significant genotype differences
in the posterior cingulate or precuneus were observed between
genotypes for both age groups. Cortical thickness: No signifi-
cant genotype differences were observed in either age group.
Correlations with performance on covert attention task: There
were no correlations between the MRI measures and task
performance for either region.
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Figure 2. Plots for the statistically-significant correlations (p < 0.05) of MR-
derived white matter volume or cortical thickness with performance in covert
attention or episodic memory tasks.
E. Hippocampus
Grey matter volume ratio: No significant genotype dif-
ferences in the hippocampal grey matter were detected for
both age groups. Correlations with performance on episodic
memory task: There were no correlations between grey matter
volume ratio and task performance.
F. Resting State MRI
1) Young group: From the results of the ICA, 8 resting state
networks were identified. These were the default mode Net-
work (DMN), Executive Control Network (ECN), left fronto-
parietal, right fronto-parietal, medial visual network, lateral
visual network, sensorimotor network, auditory network.
Voxel-wise comparisons of e4+ vs e3/e3 revealed differ-
ences within the medial visual network only. It was found that
e3/e3 showed greater functional connectivity within a portion
of this network, localised to extrastriate cortex (x = 6, y = -82,
z = -12, FWE-corrected p <0.05) (Figure 3).
2) Mid-age group: The same 8 resting state networks were
identified for the mid-age group as those found in the young
group. Voxel-wise comparisons revealed no APOE effects
within any of the networks.
IV. DISCUSSION
This study has revealed subtle, but significant, structural
differences between e3/e3 and e4+ at both young and mid-age
that complement our finding of genotype-driven microstruc-
tural differences in our young cohort, published previously
(59). The current work extends this earlier analysis in study-
ing both young and mid-age cohorts. The previous analysis
identified a subtle increase in white matter volume of e4+ in
young group, so this work has targeted specific brain regions
which have allowed us to identify regional volume and cortical
thickness differences in two age groups that could not be
detected by a whole-brain analysis. In addition, this present
study focuses on the relationship between task performance
and the structural differences in brain regions known to be im-
plicated in completion of these tasks. We found that there were
no detectable genotype-dependent differences in hippocampal
volume for either the young or mid-aged adults in this study.
This is not surprising given the somewhat conflicting findings
Figure 3. (a) The medial visual resting state network identified by ICA
in the young adult group (b) young adult e3/e3 showed greater functional
connectivity within this network as compared to e4+. The slice positions x
and y are shown on the figure.
in the literature. A recent study (45) reported that hippocampal
volume was greater in e4+ compared to e4-, but it should be
noted that the study was conducted on a cohort with a wide age
range (26-46 years) and with an average age (38 years) that
bisects our two groups. Further studies were in keeping with
our current finding that hippocampal volume does not differ
by APOE status (26) but did correlate with episodic memory
performance in e4+ in combination with other risk alleles
(22). In contrast, another study in healthy individuals aged
50-80 found that e4+ have significantly reduced hippocampal
volume and a positive correlation between recognition memory
and hippocampal volume (68). The nearby parahippocampus
is also an important region for memory processing. In this
area we found that there was a significant positive correlation
between the thickness of the parahippocampus in young e4+
and their performance on an episodic memory task, sug-
gesting that behavioural benefits may be available for e4+
with increased thickness. However, there was no evidence
that young adult e4+ had greater parahippocampal thickness
overall and nor did they perform better as a group in the
episodic memory task. In contrast, mid-age e4+ in our cohort
did not show a correlation between parahippocampal thickness
and task performance, but nevertheless possessed significantly
greater overall parahippocampal thickness, bilaterally. The left
anterior cingulate also displayed the same pattern: a positive
correlation between white matter volume and task performance
(this time in the covert attention task) was seen in young e4+
only, and increased white-matter volume was present in mid-
age e4+. The laterality of our finding in the anterior cingulate
mirrors that of a recent CBF study in APOE, where significant
genotype differences were restricted to the left-sided anterior
cingulate only (43).
The APOE gene codes for a protein that influences neuronal
development in general, through its role in the transport of
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cholesterol and lipid to structures such as the myelin sheath
(69,70). In particular, mouse studies have demonstrated that
the presence of APOE is crucial for neurogenesis (71,72) and
that the process is dependent on the interaction of APOE
isoform and environmental conditions. Several studies on
human brains (73,74) have identified that neurodegeneration in
diseases such as Huntington’s and AD is actually accompanied
by a compensatory increase in neurogenesis, at least in the
early phase of the disease. In the case of AD, the increased
volume observed in the hippocampus is not maintained but
becomes atrophic as the disease progresses. Likely candidates
for this eventual atrophy are increased cell loss coupled with
impaired neural development in the potentially toxic environ-
ment of the AD brain (74). Our study observed significantly
greater parahippocampal thickness and a trend towards greater
left anterior cingulate white matter volume in our healthy e4+
at mid-age. Studies have shown that e4+ exhibit a signifi-
cant increase in activity within the hippocampus across the
lifespan (35,75-77) possibly as a compensatory up-regulation
driven by reduced synaptic plasticity among this genetic group
(78). From a neurogenic perspective, this greater hippocampal
burden throughout life could promote enhanced neurogenesis
in this region. The presence of a neuronal bottleneck in
our e4+ could be one interpretation for the findings of the
present study, where our correlations show that if young e4+
have thinner parahippocampal cortex or smaller white matter
volume in the left anterior cingulate, they exhibit reduced per-
formance in their respective tasks. Such bottlenecks have been
demonstrated in multitasking trials where brain areas such as
the hippocampus and anterior cingulate are overactivated (79).
Increased cognitive load, in rodent studies at least, has given
rise to increased neurogenesis at the narrowest region in the
hippocampus (80). It is an intriguing possibility that an over-
engagement with parahippocampus and anterior cingulate by
e4+ throughout youth may provoke a neurogenic response that
leads to the relative enlargement in these areas, as observed
in our mid-age e4+ cohort. This pattern of non-linear cerebral
atrophy has been reported in a recent study across several key
brain areas, including the medial temporal structures (81). In
that study, a thicker parahippocampus cortex among the e4+
was observed in the prodromal AD cohort, but the increased
cortical thickness was not maintained and, mirroring previous
findings in the hippocampus (73,74), it later reverted at later
stages of the disease profile. Activity-driven changes to brain
structure are not limited to grey matter; there is evidence for
changes to axonal diameter, number of myelinated axons, and
axonal sprouting in white matter. Such changes have been
identified in the hippocampus (82) and also in the long-range
axons (83) in response to learning, exercise, or recovery from
damage. However, we present here a cross-sectional study:
the young and mid-age cohorts contain different participants
with varying social and educational backgrounds, so we are
cautious not to draw conclusions that can only be satisfactorily
made from longitudinal studies.
Our data also show several differences in the cuneus (ex-
trastriate) regions between our genotype groups. Again, there
is a positive correlation between task performance (smaller
validity effect in CA task) and cuneus white matter volume.
In contrast to the results discussed above, however, there is
a significantly greater cuneus white matter volume in e4+
compared to e3/e3 at young age. These findings are also
accompanied by the observation that the medial visual network
was found to be underactivated in young e4+ compared to
e3/e3 in just this region in resting state MRI. Various other
studies have investigated APOE effects in the resting state:
enhanced default mode network (DMN) coactivations have
been reported in e4+ both at age 20-35 (35) and 50-80 (37).
It has been shown that synchronization between hippocampus
and DMN is elevated in mid-age and elderly e4+ and this cor-
relates with memory performance; increased synchronization
was also reported in other regions including the cuneus (37).
Disrupted activity in DMN and executive control networks has
also been reported in mid-aged (45-65) e4+, again linked to
episodic memory performance (60) although we could find
no differences in DMN coactivity in either of the age groups
under study. Other work has also failed to replicate these
findings (36,84), suggesting that the exact age range and/or
other factors might be critical. Instead, we localized APOE
differences to coactivation within the medial visual resting
state network. Although we are the first study to report such
a finding, this result supports the argument that the cuneus
could be an important locus for APOE-related differences in
structure and function. Visual resting state differences were
found only in the young adult group; at mid-age, no APOE
effects on resting state networks were found. Interpreting this
result is difficult, not least because the significance of resting
state connectivity in early visual processing areas is not well
characterized. Importantly, however, the resting state data pre-
sented here, which found no differences in DMN coactivation
by genotype, suggests that differences reported by (60) could
have resulted from the inclusion of older adults in their sample.
The current findings suggest that DMN coactivity does not
differentiate e4+ and e3/e3 until at least age 55. Alternatively,
lifestyle factors and educational attainment could be critical;
further work is needed to investigate these.
This study has several limitations. Importantly, this is a
cross-sectional study that recruited healthy participants with
a range of educational and social backgrounds across the age
groups and, therefore, a direct study of age and genotype
interactions cannot be performed. Nevertheless, our findings
raise some important questions about the interaction of brain
function and structure across APOE genotypes that can only
be resolved by future longitudinal studies. A further limitation
is use of the Freesurfer software package, which does not
always provide accurate estimates of the surfaces of the pial
and grey matter in the temporal lobes of the brain. It is im-
portant, therefore, that this study recruited compliant, healthy
volunteers that provided good quality images, requiring limited
minor edits to the automated segmentation. Also, unreliable
segmentation would reduce the precision of thickness and vol-
ume measures in all participants, without bias towards either
genotype group. This would result in a reduced sensitivity to
identifying group differences (i.e. more false negatives) and,
in turn, true differences would need to be large or consistent
across the group to be statistically significant. Finally, although
we had a good sample size for this study, we did not include
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either a homozygous APOE-e4 group, or an e2 group; the very
low prevalence of these genotype configurations in the natural
population requires a larger study and much wider genotype
screening.
V. CONCLUSION
APOE status is known to affect the function of the human
brain throughout the lifespan and many functional and resting
state MRI studies have revealed differences between e4+ and
e4-. The cuneus seems to be one of the first sites where
amyloid is deposited in AD and, in this work, we have found
that the cuneus appears to be an important locus for genotype
differences with greater functional connectivity among the
young e3/e3 and greater white matter volume in young e4+.
In addition, we have correlated functional and behavioural
differences with brain structure and found that subtle cortical
thickness measures in the parahippocampus of our young e4+
positively correlate with performance on a memory task. A
similar correlation with white matter volume was found in the
left anterior cingulate on a covert attention task, suggesting
that behavioural benefits may be available for e4+ with either
increased cortical thickness or volume in these regions. In
our mid-age cohort we see significant structural differences
in these same regions: the parahippocampal cortical thickness
and left anterior cingulate white matter volumes were both
significantly greater for e4+ compared to e3/e3, offering the
intriguing possibility that the greater engagement with these
regions in youth may lead to observable neurogenic structural
changes by mid age. These changes are not associated with
behavioural benefits in younger adults, and may underwrite
the absence of behavioural deficits in e4+ at mid age.
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